Health Condition 1: L811- Chloasma
Conditions
Interventions
None listed
Sponsors
Dr Kiran sidram ranbhirkar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female patients, aged 18 54 years 2. Clinical features consistent with Vyanga (Melasma): tan to brown, symmetrical, blotchy facial hyperpigmentation located on forehead, cheeks, temples, upper lip, etc. 3.No specific treatment for Vyanga in the 1 month prior to enrolment. 4. Willingness to participate and provide informed consent (or assent with parental/guardian consent for minors).
Exclusion criteria
Exclusion criteria: 1. Age below 18 years or greater than 54 years. 2. Current use of oral contraceptive pills or depot/injectable contraceptives. 3. Other causes of facial pigmentation (e.g., freckles, nevi, nutritional or drug-induced pigmentation, postinflammatory hyperpigmentation). 4. Presence of active inflammation at lesion site (prominent itching, swelling, oozing or secondary infection). 5. Occupational or other consistent sun exposure that cannot be modified or controlled during the study. 6. Pregnancy or lactation.Significant systemic illness (e.g., uncontrolled endocrine, hepatic, renal disease) or any condition that may interfere with study participation or assessments. 7. Known allergy or hypersensitivity to any component of the study formulations. 8. Participation in another clinical trial within the preceding 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in sign and symptoms of vyangya such as Reduction in pigmentation patches (size, color, intensity),kandu daha and rukshataTimepoint: Duration of study-18 months duration of treatment - 30 days Assessment on 0,15th and 30th day | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr Swati soman
Sst ayurved mahavidyalaya sangamner
Outcome results
None listed